Form 4: Biodesix CEO Scott Hutton Reports Stock Sales to Cover RSU Vesting Taxes
SEC Form 4 Filing
Biodesix CEO Scott Hutton sold shares of common stock to cover taxes upon the vesting of restricted stock units (RSUs).
Summary
- On May 9, 2025, Scott Hutton, the President and CEO of Biodesix Inc., acquired 12,212 shares of common stock through the vesting of restricted stock units.
- Following this transaction, Hutton directly owned 724,159 shares of Biodesix common stock.
- On May 12 and 13, 2025, Hutton sold 1,888 and 1,887 shares, respectively, to cover taxes associated with the vesting of these RSUs.
- The sale prices were $0.3594 and $0.3529 per share, respectively.
- After these sales, Hutton directly owned 722,271 and 720,384 shares of Biodesix common stock, respectively.
- The RSUs vest in sixteen quarterly installments from February 8, 2022.
Sentiment
Score: 5
Explanation: This Form 4 filing is a routine disclosure of stock sales to cover taxes related to RSU vesting, which is a neutral event.
Industry Context
This is a routine filing related to insider transactions, specifically the sale of shares to cover tax obligations arising from the vesting of restricted stock units. Such transactions are common among executives and do not necessarily indicate a change in the executive's confidence in the company.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units (RSUs) that vest over time.
- It is standard practice for executives to sell a portion of the shares acquired through vesting to cover the associated tax liabilities.
- The weighted average prices of $0.3594 and $0.3529 per share are within a normal range for companies in a similar financial position to Biodesix.
- Comparable companies such as Exact Sciences and Guardant Health also see similar transactions from their executives.
Key Dates
| Date | Description |
|---|---|
| 02/08/2022 | Date from which RSUs vest in sixteen successive quarterly installments |
| 02/28/2025 | 10,000 shares purchased under the Issuer's Employee Stock Purchase Plan |
| 05/09/2025 | Date of RSU vesting resulting in acquisition of 12,212 shares |
| 05/12/2025 | Date of stock sale of 1,888 shares at $0.3594 to cover taxes |
| 05/13/2025 | Date of stock sale of 1,887 shares at $0.3529 to cover taxes |
Keywords
Form 4, insider trading, stock sale, restricted stock units, Biodesix, BDSX, Scott Hutton, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.